AVT29
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AVT29, covering 2026-03-23 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema [Phase 3]